|
original article |
Journal |
Date |
Title |
Authors All Authors |
1 |
[GO] |
FOCUS Endocrinology |
2025―May―16 |
Case report of mucormycosis in a diabetic patient after suffering a coronavirus infection |
D. Sh. Аvzаlеtdinоvа, O. U. Ibrаgimоvа, A. Z. Bulgаkоvа |
2 |
[GO] |
FOCUS Endocrinology |
2024―Nov―15 |
Understanding the influence of COVID-19 on pancreatic exocrine and endocrine function: сlinical and pathogenetic insights and their correlation with infection severity |
M.E. Zharova, E.L. Nikonov, I.O. Ivanikov, Yu.V. Grigoryeva |
3 |
[GO] |
FOCUS Endocrinology |
2024―Jun―14 |
Diabetes- associated factors in hospitalized COVID-19 patients with concomitant type 2 diabetes mellitus: focus on mean in-hospital glycemic values |
D. V. Belkina, T. A. Nekrasova, L. G. Strongin, E. M. Durygina, M. Yu. Rodina |
4 |
[GO] |
FOCUS Endocrinology |
2024―May―25 |
The therapeutic potential of the use of gliclazide MV in combination with COVID-19 and type 2 diabetes mellitus |
D. V. Belikina, T. A. Nekrasova, L. G. Strongin, E. M. Durygina, M. Yu. Rodina |
5 |
[GO] |
FOCUS Endocrinology |
2024―May―25 |
Course of coronavirus infection in patients with type 2 diabetes mellitus |
Z. Sh. Khamidullina, D. Sh. Avzaletdinova, T. V. Morugova, N. Sh. Zagidullin, D. F. Gareeva |
6 |
[GO] |
FOCUS Endocrinology |
2024―May―23 |
The therapeutic potential of the use of gliclazide MV in combination with COVID-19
and type 2 diabetes mellitus |
D.V. Belikina, T. A Nekrasova, L.G. Strongin, E. M. Durygina, M. Yu. Rodina |
7 |
[GO] |
FOCUS Endocrinology |
2024―May―23 |
Course of coronavirus infection in patients with type 2 diabetes mellitus |
Z. Sh. Khamidullina, D. Sh. Avzaletdinova, T.V. Morugova, N. Sh. Zagidullin, D. F. Gareeva |